Your weekly roundup of the latest news from Drug Topics®.
The decision comes following reports of 16,000 cases across 75 countries and territories around the world.
Research examines whether a step-approach with treatment for macular edema produces positive results.
Fentanyl, COVID-19 pandemic likely factors in 30% increase from previous year.
Novo Nordisk’s Saxenda (liraglutide) and Wegovy (semaglutide) are leading the way for a new crop of drugs that reduce appetite, but the cost-effectiveness is in question with many payers saying no to coverage.
Research indicates that the risk of certain conditions becomes significantly increased following a bout of COVID-19.
Q&A: Pharmacist-Led Diabetes Management Transforms Patient Care and Clinical Outcomes
June 28th 2025An ambulatory care pharmacist program in Washington State dramatically improved diabetes management by reducing A1c levels, increasing medication adherence, and providing comprehensive patient education.